Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,429 | -84,413 | -48,482 | -36,882 | -18,627 |
| Depreciation Amortization | 602 | 42,825 | 1,407 | 814 | 334 |
| Income taxes - deferred | N/A | -24,320 | N/A | N/A | N/A |
| Accounts receivable | -317 | -129 | -573 | -914 | -7,605 |
| Other Working Capital | -3,812 | 3,147 | -3,398 | 4,123 | -4,401 |
| Other Operating Activity | 989 | 14,250 | 12,748 | 10,242 | 12,764 |
| Operating Cash Flow | $-19,967 | $-48,640 | $-38,298 | $-22,617 | $-17,535 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 35,086 | 34,192 | 28,349 | 26,618 |
| PPE Investments | -248 | -7,261 | -7,076 | -6,539 | -3,423 |
| Purchase Of Investment | -75,418 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-75,666 | $27,825 | $27,116 | $21,810 | $23,195 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 66,368 | 453 | 419 | 358 | 354 |
| Other Financing Activity | -12,001 | 48,869 | 0 | 0 | 0 |
| Financing Cash Flow | $54,367 | $49,322 | $419 | $358 | $354 |
| Exchange Rate Effect | -565 | 2,372 | 2,575 | 1,248 | 424 |
| Beginning Cash Position | 54,292 | 23,413 | 23,413 | 23,413 | 23,413 |
| End Cash Position | 12,461 | 54,292 | 15,225 | 24,212 | 29,851 |
| Net Cash Flow | $-41,831 | $30,879 | $-8,188 | $799 | $6,438 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,967 | -48,640 | -38,298 | -22,617 | -17,535 |
| Capital Expenditure | -248 | -7,264 | -7,076 | -6,539 | -3,423 |
| Free Cash Flow | -20,215 | -55,904 | -45,374 | -29,156 | -20,958 |